Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert Deray

Showing results (201-210 of 213) with videos related to

Pageof 22
Sort By:
Nephrologie & Therapeutique|November 26, 2008
[Vascular and renal effects of anti-angiogenic therapy]Jean-Michel Halimi, Michel Azizi, Guillaume Bobrie, et al.
Clinical Kidney Journal|June 23, 2017
Course of chronic kidney disease in French patientsNicolas Janus, Vincent Launay-Vacher, Laurent Juillard, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 8, 2014
Prevalence of renal abnormalities in chronic HBV infection: the HARPE studySabine Amet, Jean-Pierre Bronowicki, Dominique Thabut, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 22, 2020
Antifungal Stewardship in Hematology: Reflection of a Multidisciplinary Group of ExpertsMauricette Michallet, Mohamad Sobh, Gilbert Deray, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|February 26, 2024
Risk Profiles and Treatment Patterns in Atrial Fibrillation Patients with Chronic Kidney Disease Receiving or not Receiving Anticoagulation TherapyReinhold Kreutz, Gilbert Deray, Jürgen Floege, et al.
Gastroenterology|September 27, 2013
Telbivudine improves renal function in patients with chronic hepatitis BEdward J Gane, Gilbert Deray, Yun-Fan Liaw, et al.
European Radiology|December 6, 2012
Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)Gilbert Deray, Olivier Rouviere, Lorenzo Bacigalupo, et al.
JACC. Advances|June 28, 2024
Rivaroxaban vs Vitamin K Antagonist in Patients With Atrial Fibrillation and Advanced Chronic Kidney DiseaseReinhold Kreutz, Gilbert Deray, Jürgen Floege, et al.
Nephrologie & Therapeutique|December 17, 2008
[Position statements regarding usage of biosimilars of Epoetins. Position paper of the Société de néphrologie, Société francophone de dialyse, and Société de néphrologie pédiatrique]Jean-Louis Bouchet, Philippe Brunet, Bernard Canaud, et al.
Urolithiasis|February 28, 2022
How the diagnosis and the management of genetic renal phosphate leak impact the life of kidney stone formers?Isabelle N Tostivint, Rita G Araman, Vincent Castiglione, et al.
Pageof 22

Showing results (201-210 of 213) with videos related to

Sort By:
Pageof 22
Nephrologie & Therapeutique|November 26, 2008
[Vascular and renal effects of anti-angiogenic therapy]Jean-Michel Halimi, Michel Azizi, Guillaume Bobrie, et al.
Clinical Kidney Journal|June 23, 2017
Course of chronic kidney disease in French patientsNicolas Janus, Vincent Launay-Vacher, Laurent Juillard, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 8, 2014
Prevalence of renal abnormalities in chronic HBV infection: the HARPE studySabine Amet, Jean-Pierre Bronowicki, Dominique Thabut, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 22, 2020
Antifungal Stewardship in Hematology: Reflection of a Multidisciplinary Group of ExpertsMauricette Michallet, Mohamad Sobh, Gilbert Deray, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|February 26, 2024
Risk Profiles and Treatment Patterns in Atrial Fibrillation Patients with Chronic Kidney Disease Receiving or not Receiving Anticoagulation TherapyReinhold Kreutz, Gilbert Deray, Jürgen Floege, et al.
Gastroenterology|September 27, 2013
Telbivudine improves renal function in patients with chronic hepatitis BEdward J Gane, Gilbert Deray, Yun-Fan Liaw, et al.
European Radiology|December 6, 2012
Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)Gilbert Deray, Olivier Rouviere, Lorenzo Bacigalupo, et al.
JACC. Advances|June 28, 2024
Rivaroxaban vs Vitamin K Antagonist in Patients With Atrial Fibrillation and Advanced Chronic Kidney DiseaseReinhold Kreutz, Gilbert Deray, Jürgen Floege, et al.
Nephrologie & Therapeutique|December 17, 2008
[Position statements regarding usage of biosimilars of Epoetins. Position paper of the Société de néphrologie, Société francophone de dialyse, and Société de néphrologie pédiatrique]Jean-Louis Bouchet, Philippe Brunet, Bernard Canaud, et al.
Urolithiasis|February 28, 2022
How the diagnosis and the management of genetic renal phosphate leak impact the life of kidney stone formers?Isabelle N Tostivint, Rita G Araman, Vincent Castiglione, et al.
Pageof 22